Andrew Dudum, Chief Executive Officer at Hims & Hers Health, Inc. (HIMS), sold 130,220 shares at $50.57 ($6.6M) on 2025-09-17, disclosed to the SEC on 2025-09-19.
Scheduled sale ($6.6M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.57 | 65,110 | $3.3M | 50.0% |
| 2 | $50.57 | 65,110 | $3.3M | 50.0% |
| Total | $50.57 avg | 130,220 | $6.6M | 100% |
| Filing → |
| HIMS | SELL | 2025-08-20 | $13.6M | — | Filing → |
| HIMS | SELL | 2025-08-11 | $33.4M | — | Filing → |
| HIMS | SELL | 2025-07-23 | $9.9M | — | Filing → |